<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>7</volume><submitter>Pereira-Fantini PM</submitter><pubmed_abstract>Liver disease is a major source of morbidity and mortality in children with short bowel syndrome (SBS). SBS-associated microbial dysbiosis has recently been implicated in the development of SBS-associated liver disease (SBS-ALD), however the pathological implications of this association have not been explored. In this study high-throughput sequencing of colonic content from the well-validated piglet SBS-ALD model was examined to determine alterations in microbial communities, and concurrent metabolic alterations identified in urine samples via targeted mass spectrometry approaches (GC-MS, LC-MS, FIA-MS) further uncovered impacts of microbial disturbance on metabolic outcomes in SBS-ALD. Multi-variate analyses were performed to elucidate contributing SBS-ALD microbe and metabolite panels and to identify microbe-metabolite interactions. A unique SBS-ALD microbe panel was clearest at the genus level, with discriminating bacteria predominantly from the Firmicutes and Bacteroidetes phyla. The SBS-ALD metabolome included important alterations in the microbial metabolism of amino acids and the mitochondrial metabolism of branched chain amino acids. Correlation analysis defined microbe-metabolite clustering patterns unique to SBS-ALD and identified a metabolite panel that correlates with dysbiosis of the gut microbiome in SBS.</pubmed_abstract><journal>Scientific reports</journal><pagination>43326</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC5322370</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Unravelling the metabolic impact of SBS-associated microbial dysbiosis: Insights from the piglet short bowel syndrome model.</pubmed_title><pmcid>PMC5322370</pmcid><pubmed_authors>Pereira-Fantini PM</pubmed_authors><pubmed_authors>Lapthorne S</pubmed_authors><pubmed_authors>Pitt J</pubmed_authors><pubmed_authors>Bines JE</pubmed_authors><pubmed_authors>Byars SG</pubmed_authors><pubmed_authors>Fouhy F</pubmed_authors><pubmed_authors>Cotter PD</pubmed_authors></additional><is_claimable>false</is_claimable><name>Unravelling the metabolic impact of SBS-associated microbial dysbiosis: Insights from the piglet short bowel syndrome model.</name><description>Liver disease is a major source of morbidity and mortality in children with short bowel syndrome (SBS). SBS-associated microbial dysbiosis has recently been implicated in the development of SBS-associated liver disease (SBS-ALD), however the pathological implications of this association have not been explored. In this study high-throughput sequencing of colonic content from the well-validated piglet SBS-ALD model was examined to determine alterations in microbial communities, and concurrent metabolic alterations identified in urine samples via targeted mass spectrometry approaches (GC-MS, LC-MS, FIA-MS) further uncovered impacts of microbial disturbance on metabolic outcomes in SBS-ALD. Multi-variate analyses were performed to elucidate contributing SBS-ALD microbe and metabolite panels and to identify microbe-metabolite interactions. A unique SBS-ALD microbe panel was clearest at the genus level, with discriminating bacteria predominantly from the Firmicutes and Bacteroidetes phyla. The SBS-ALD metabolome included important alterations in the microbial metabolism of amino acids and the mitochondrial metabolism of branched chain amino acids. Correlation analysis defined microbe-metabolite clustering patterns unique to SBS-ALD and identified a metabolite panel that correlates with dysbiosis of the gut microbiome in SBS.</description><dates><release>2017-01-01T00:00:00Z</release><publication>2017 Feb</publication><modification>2024-11-06T13:27:08.833Z</modification><creation>2019-03-27T02:37:10Z</creation></dates><accession>S-EPMC5322370</accession><cross_references><pubmed>28230078</pubmed><doi>10.1038/srep43326</doi></cross_references></HashMap>